BMS and AstraZeneca join the GLP-1 rumble
July 02 2012
AstraZeneca is going in on an acquisition of Amylin with its Onglyza partner Bristol-Myers Squibb.
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.